Partner with the Leaders Building Medtech

Patrick Anquetil

CEO

Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration. Visit website.

Alan Lucas

CEO

Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. Visit website.

Ash Attia

CEO

BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

Berk Tas

CEO

Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website.

Yossi Bar

CEO

LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

Patryk Kania

CEO and President

Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website.

David Constantine

CEO

Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website.

Thea Wulff Olesen

CEO

Ossiform is the developer of fully resorbable patient-matched implants, tailored to improve bone healing outcomes in orthopedics and spine. According to Ossiform: We Print Bone™. Visit website.

Gopal K. Chopra

Co-CEO

CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website

Henry (Chip) Appelbaum

President & CEO

Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation. Visit website.

Olivier Delporte

CEO

SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory.  Visit website.

Scott Gunnigle

CEO

Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options. Visit website.

Carlos Bremer

President North American Division

Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website.

Dimitri Sokolov

CEO

Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation.  Visit website.

Vijit Sabnis

Co-Founder

Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology.

Augustine Lien

CEO

Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults. Visit website.

Christian Pean

CEO

Azra Care is a healthcare technology company specializing in integrating SaaS AI solutions into orthopedic care to enhance patient outcomes and operational efficiency. The company’s platform leverages advanced analytics and machine learning to support evidence-based, equity-focused clinical decision-making and population health management. Azra Care is committed to transforming orthopedic surgery and care delivery through innovative, value-based approaches that address racial disparities and improve healthcare access for all. Visit website.

Bradford Conlan

CEO

Bimini Healthtech is developing a diverse portfolio of regenerative technologies and therapeutics that enable people to live better lives. The company is commercializing and investigating autologous and allogenic products and therapies intended for use at the point-of-care to eliminate the need for matching patients with donors.  Visit website.

David Danielsen

CEO

CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website.

Manfred Franke

CEO

Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration. Visit website.

Jochen Hampe

CEO

ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website.

Bora Chang

Founder & CEO

The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website.

Surendar Magar

CEO

Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software. Visit website.

Richard Hughen

CEO

Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops. Visit website.

Ana Maiques

CEO

Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. Visit website.

David Thompson

CEO

Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients.  Visit website.

Brian Kannard

Founder

PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment. Visit website.

Richard Hanbury

CEO

Non-invasive bio-therapeutic device for pain management. Visit website.

Roberta Lee

CEO

Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system. Visit website.

Upma Sharma

President & CEO

Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage.  Visit website.

Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visite website.

Stuart Simpson

CEO

THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website.

Peter Vranes

CEO

Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.  Visit website.

Dimitrios Angelis

Co-Founder

The first osseointegrative biomimetic knee cartilage implant. Visit website.

Jennifer Fried

CEO

Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website.

Cary Vance

CEO

The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates. Visit website.

Erika Chen

Business Development Lead

Pulnovo Medical is developing radiofrequency (RF) solutions for the treatment of pulmonary hypertension. PADN is a multipolar synchronous pulmonary artery RF ablation catheter that is intended to treat pulmonary hypertension by ablating the sympathetic nerve at the target site. The device is capable of point-to-point ablation of pulmonary sympathetic nerves. Visit website.

Marcin Golebicki

CEO

EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website.

Sanjeev Bhatia

CEO

Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery. Visit website.

Solveig Johannessen

CEO

Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

Ilan Uchitel

CEO & Co-Founder

CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue.  Visit website.

Per Langoe

CEO

GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complication while optimizes therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTile's provide uniform radiation-source spacing to ensure even dose distribution.  Visit website.

Gulam Khan

CEO

Centerline is a Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS®) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.

Altra has engineered a novel infusion pump, inspired by the human heart, to address adverse events and challenges associated with drug delivery. The company's infusion pump utilizes dual chamber pumping technology to enable safe and effective infusion therapy. Visit website. 

Leo Smit

CEO

Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

Chris Barron

CEO

EMBioSys develops non-invasive, electrode-free, home-use wearable garments that utilize low level induced electric fields (iEFs) for the treatment of solid metastatic cancers. iEF Therapy hinders metastasis while potentiating new opportunities to improve the standard of care and patient outcomes. Visit website.

Declan Soden

CEO

Mirai Medical ePORE therapy is a unique precision therapy platform that targets and destroy tumor tissue without harming surrounding healthy tissue. The minimally invasive technology delivers pulsed electrical fields that create pores in the cell membrane of tumor cells, catalyzing cellular death. Mirai's technology has been developed for external (skin) and internal (endoscopic) tumor treatment.  Visit website.

Nelson Patterson

CEO

Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average. Visit website.